Figure 5From: Inhibiting CB1 receptors improves lipogenesis in an in vitro non-alcoholic fatty liver disease modelThe expressions of lipogenesis factors in HepG2 liver cells. A. The mRNA expression of lipogenesis factors in HepG2 liver cells. B. The protein expression of lipogenesis factors in HepG2 liver Cells. C-E. The protein expression fold change. HepG2; HepG2-fatty; Rimonabant/HepG2-fatty. “Violet square symbol” HepG2 cell, “red square symbol” HepG2-fatty liver cell, “yellow square symbol” Rimonabant/HepG2-fatty liver cell.Back to article page